| Product Code: ETC9956361 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Therapeutic Vaccines Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Therapeutic Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Therapeutic Vaccines Market - Industry Life Cycle |
3.4 United Kingdom (UK) Therapeutic Vaccines Market - Porter's Five Forces |
3.5 United Kingdom (UK) Therapeutic Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United Kingdom (UK) Therapeutic Vaccines Market Revenues & Volume Share, By Therapeutic Vaccines, 2021 & 2031F |
4 United Kingdom (UK) Therapeutic Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in the UK, driving the demand for therapeutic vaccines. |
4.2.2 Rising awareness about preventive healthcare measures and the benefits of therapeutic vaccines. |
4.2.3 Growing government support and funding for vaccination programs in the UK. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and lengthy approval processes for therapeutic vaccines. |
4.3.2 Limited availability of skilled healthcare professionals to administer vaccines effectively. |
5 United Kingdom (UK) Therapeutic Vaccines Market Trends |
6 United Kingdom (UK) Therapeutic Vaccines Market, By Types |
6.1 United Kingdom (UK) Therapeutic Vaccines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Therapeutic Vaccines Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United Kingdom (UK) Therapeutic Vaccines Market Revenues & Volume, By Peptide Therapeutic Vaccine, 2021- 2031F |
6.1.4 United Kingdom (UK) Therapeutic Vaccines Market Revenues & Volume, By Cell Therapeutic Vaccine, 2021- 2031F |
6.1.5 United Kingdom (UK) Therapeutic Vaccines Market Revenues & Volume, By Nucleic Acid Therapeutic Vaccine, 2021- 2031F |
6.2 United Kingdom (UK) Therapeutic Vaccines Market, By Therapeutic Vaccines |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Therapeutic Vaccines Market Revenues & Volume, By Oncotherapy, 2021- 2031F |
6.2.3 United Kingdom (UK) Therapeutic Vaccines Market Revenues & Volume, By Hepatitis B, 2021- 2031F |
6.2.4 United Kingdom (UK) Therapeutic Vaccines Market Revenues & Volume, By Tuberculosis, 2021- 2031F |
6.2.5 United Kingdom (UK) Therapeutic Vaccines Market Revenues & Volume, By Herpes Simplex Virus, 2021- 2031F |
6.2.6 United Kingdom (UK) Therapeutic Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
7 United Kingdom (UK) Therapeutic Vaccines Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Therapeutic Vaccines Market Export to Major Countries |
7.2 United Kingdom (UK) Therapeutic Vaccines Market Imports from Major Countries |
8 United Kingdom (UK) Therapeutic Vaccines Market Key Performance Indicators |
8.1 Percentage increase in public vaccination coverage rates. |
8.2 Number of new therapeutic vaccine approvals by regulatory authorities in the UK. |
8.3 Research and development investment in innovative vaccine technologies. |
9 United Kingdom (UK) Therapeutic Vaccines Market - Opportunity Assessment |
9.1 United Kingdom (UK) Therapeutic Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United Kingdom (UK) Therapeutic Vaccines Market Opportunity Assessment, By Therapeutic Vaccines, 2021 & 2031F |
10 United Kingdom (UK) Therapeutic Vaccines Market - Competitive Landscape |
10.1 United Kingdom (UK) Therapeutic Vaccines Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Therapeutic Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here